Beschreibung:
<jats:p>We assessed the roles of Ca<jats:sup>2+</jats:sup> release, the electron transport chain and NOX in hypoxic pulmonary vasoconstriction (HPV), the process by which hypoxia constricts pulmonary arteries (PA). HPV in the absence of pretone in 2<jats:sup>nd</jats:sup> and 3<jats:sup>rd</jats:sup> order rat PA branches gassed with 95% N<jats:sub>2</jats:sub>, 5% CO<jats:sub>2</jats:sub> for 40 min demonstrated an initial transient tension increase (phase 1) followed by a slow rise in tension (phase 2). Phase 1 was abolished but phase 2 was unaffected by the complex I inhibitor rotenone (1 μM). Both phases of HPV were abolished by the complex IV inhibitor cyanide (10 μM). Pretreatment of PA with superoxide dismutase (200 units/ml), catalase (200 units/ml), their combination, or with the putative NOX inhibitor VAS 2870 (10 μM) had no effect on either phase of HPV. The superoxide scavenger TEMPOL (3mM) reduced phase 1 by 42% and abolished phase 2. 10 μM NED‐19 had no effect on either phase of HPV. The PKC blocker Gö6983 (3 μM) reduced both phases by ~30%. Pretreatment with 100 μM ryanodine reduced both phases 1 by ~70%. Pretreatment with a combination of ryanodine (10 μM) and caffeine (10 mM) to deplete SR Ca<jats:sup>2+</jats:sup> abolished both phases. Applying zero Ca<jats:sup>2+</jats:sup> ‐PSS ablated phase 1 HPV but had no effect on phase 2, and re‐adding Ca<jats:sup>2+</jats:sup> during phase 2 did not increase contraction. These data indicate that O<jats:sub>2</jats:sub> sensing mechanisms for phase 1 and 2 differ, but in neither case involve NOX. Phase 2 HPV is apparently fully accounted for by the release of Ca<jats:sup>2+</jats:sup> from the SR.</jats:p>